Wall Street Journal -- The Food and Drug Administration is a bottleneck delaying the launch of medical devices in the U.S., says a new study supported by the National Venture Capital Association and the Medical Device Manufacturers Association. European regulatory agencies are more predicable and transparent than the FDA, said most of the 204 private and publicly traded companies responding to the survey. The agency’s medical device unit has grown increasingly conservative and is now over-emphasizing safety, the study found. It was co-authored by Josh Makower, a venture partner at New Enterprise Associates, one of the largest U.S. venture firms, and Aabed Meer, an MD-MBA degree candidate at Stanford University. Read more in today’s VentureWire. Find the med tech innovation report and related information here.
